Literature DB >> 25009081

Massive pulmonary embolism and cardiac arrest; thrombolytic therapy in a patient with recent intracranial surgery and glioblastoma multiforme.

Başak Bayram1, Neşe Çolak Oray2, Emel Korkmaz3, Hale Aksu Erdost4, Necati Gokmen5.   

Abstract

Treatment options for pulmonary embolism are increasing, but the scale of the treatments and their availability in the emergency department (ED) are limited. Thrombolytic therapy remains the most commonly used treatment in patients who present a massive pulmonary embolism in the ED. However, systemic thrombolysis is contraindicated in certain cases, such as a known intracranial tumor or a history of cranial surgery.In this case report, we report a 63-year-old man with a history of intracranial surgery due to glioblastoma multiforme 20 days prior to being admitted to the ED. Multidetector-row computed tomography angiography revealed embolisms in both main pulmonary arteries.There was a progression of cardiac arrest while preparing for catheterization; thus, cardiopulmonary resuscitation was initiated.After administering 10 minutes of cardiopulmonary resuscitation, a50-mg alteplase bolus was given. Within minutes, a pulse has returned. No complications associated with the thrombolytic therapy were observed.Our aim was to discuss the management of massive pulmonary embolism with a contraindication to systemic thrombolytic therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25009081     DOI: 10.1016/j.ajem.2014.04.022

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  2 in total

Review 1.  Ischaemic stroke in the setting of glioblastoma: A case series and review of the literature.

Authors:  Arian Lasocki; Frank Gaillard
Journal:  Neuroradiol J       Date:  2016-03-17

2.  Systemic thrombolysis in a patient with massive pulmonary embolism and recent glioblastoma multiforme resection.

Authors:  Joshua Lampert; Behnood Bikdeli; Philip Green; Matthew R Baldwin
Journal:  BMJ Case Rep       Date:  2017-11-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.